Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study.

Mitchell I, Finfer S, Bellomo R, Higlett T; ANZICS Clinical Trials Group Glucose Management Investigators.

Intensive Care Med. 2006 Jun;32(6):867-74. Epub 2006 Apr 19.

PMID:
16622639
2.

Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change.

Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C.

Crit Care. 2008;12(2):R49. doi: 10.1186/cc6868. Epub 2008 Apr 16.

3.

Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.

Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G.

Crit Care Med. 2010 Apr;38(4):1021-9. doi: 10.1097/CCM.0b013e3181cf710e.

PMID:
20124887
4.

Glucose control and mortality in critically ill patients.

Finney SJ, Zekveld C, Elia A, Evans TW.

JAMA. 2003 Oct 15;290(15):2041-7.

PMID:
14559958
5.

Sodium administration in critically ill patients in Australia and New Zealand: a multicentre point prevalence study.

Bihari S, Peake SL, Seppelt I, Williams P, Bersten A; George Institute for Global Health; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2013 Dec;15(4):294-300.

PMID:
24289511
6.

Blood glucose control in critically ill adults and children: a survey on stated practice.

Hirshberg E, Lacroix J, Sward K, Willson D, Morris AH.

Chest. 2008 Jun;133(6):1328-1335. doi: 10.1378/chest.07-2702. Epub 2008 Mar 13.

PMID:
18339779
7.

Early blood glucose control and mortality in critically ill patients in Australia.

Bagshaw SM, Egi M, George C, Bellomo R; Australia New Zealand Intensive Care Society Database Management Committee.

Crit Care Med. 2009 Feb;37(2):463-70. doi: 10.1097/CCM.0b013e318194b097.

PMID:
19114915
8.

Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study.

Kaukonen KM, Bailey M, Pilcher D, Orford N, Finfer S, Bellomo R.

Crit Care. 2013 Oct 2;17(5):R215. doi: 10.1186/cc13030.

9.

[The association between early blood glucose fluctuation and prognosis in critically ill patients].

Tang J, Gu Q.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Jan;24(1):50-3. Chinese.

10.

Glucose control, organ failure, and mortality in pediatric intensive care.

Yung M, Wilkins B, Norton L, Slater A; Paediatric Study Group; Australian and New Zealand Intensive Care Society.

Pediatr Crit Care Med. 2008 Mar;9(2):147-52. doi: 10.1097/PCC.0b013e3181668c22.

PMID:
18477927
11.

Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.

Robertson MS, Nichol AD, Higgins AM, Bailey MJ, Presneill JJ, Cooper DJ, Webb SA, McArthur C, MacIsaac CM; VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2010 Mar;12(1):9-15.

PMID:
20196708
12.

Prospective operationalization and feasibility of a glycemic control protocol in critically ill children.

Branco RG, Xavier L, Garcia PC, Piva JP, Fiori HH, Baldisserotto M, Fiori RM, Tasker RC.

Pediatr Crit Care Med. 2011 May;12(3):265-70. doi: 10.1097/PCC.0b013e3181f52847.

PMID:
20935589
13.

Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis.

Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, Hart GK, Bellomo R.

Crit Care. 2009;13(2):R45. doi: 10.1186/cc7768. Epub 2009 Apr 1.

14.

Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity.

Hirshberg E, Larsen G, Van Duker H.

Pediatr Crit Care Med. 2008 Jul;9(4):361-6. doi: 10.1097/PCC.0b013e318172d401.

PMID:
18496414
15.

Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.

Moran JL, Bristow P, Solomon PJ, George C, Hart GK; Australian and New Zealand Intensive Care Society Database Management Committee (ADMC).

Crit Care Med. 2008 Jan;36(1):46-61.

PMID:
18090383
16.

Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients.

der Voort PH, Feenstra RA, Bakker AJ, Heide L, Boerma EC, van der Horst IC.

Clin Endocrinol (Oxf). 2006 Feb;64(2):141-5.

PMID:
16430711
17.

Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes.

Lanspa MJ, Hirshberg EL, Phillips GD, Holmen J, Stoddard G, Orme J.

Chest. 2013 May;143(5):1226-1234. doi: 10.1378/chest.12-2072.

18.

The impact of early hypoglycemia and blood glucose variability on outcome in critical illness.

Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C; ANZICS CORE Management Committee.

Crit Care. 2009;13(3):R91. doi: 10.1186/cc7921. Epub 2009 Jun 17.

19.

Liberal Versus Conventional Glucose Targets in Critically Ill Diabetic Patients: An Exploratory Safety Cohort Assessment.

Di Muzio F, Presello B, Glassford NJ, Tsuji IY, Eastwood GM, Deane AM, Ekinci EI, Bellomo R, MÃ¥rtensson J.

Crit Care Med. 2016 Sep;44(9):1683-91. doi: 10.1097/CCM.0000000000001742.

PMID:
27046086
20.

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D.

CMAJ. 2009 Apr 14;180(8):821-7. doi: 10.1503/cmaj.090206. Epub 2009 Mar 24. Review.

Supplemental Content

Support Center